Kylee Eblin
About Kylee Eblin
Kylee Eblin is the Executive Director of Global Consumer Brands Supply Chain at SC Johnson, specializing in global product qualification, commercialization, and regulatory affairs.
Title and Current Position
Kylee Eblin is the Executive Director of Global Consumer Brands Supply Chain at SC Johnson in Racine, Wisconsin, United States. In her role, she is responsible for overseeing the supply chain operations for SC Johnson's global consumer brands.
Educational Background
Kylee Eblin holds a PhD in Pharmacology and Toxicology from the University of Arizona, where she studied from 2003 to 2008. She also earned a Bachelor of Science in Chemistry from Illinois Wesleyan University, completing her studies there from 1999 to 2003.
Global Product Qualification and Commercialization
Kylee Eblin has extensive experience in global product qualification and commercialization. This includes coordinating global testing in non-animal methods for non-registered products, encompassing clinical and alternative/in vitro methods. She also spearheads new laboratory qualifications, focusing on Quality Assurance, assay development, and protocol review.
Expertise in International Registration and Regulatory Affairs
Eblin specializes in international Registration and Regulatory Affairs with a particular focus on Asia. Her work includes developing global process flows for Global Safety and Regulatory Affairs to expedite market entry and define clear safety requirements for each product type. Additionally, she manages global fragrance modifications in compliance with IFRA, industry, and government regulations.
Leadership in Organizational Re-Design
At SC Johnson, Kylee Eblin has led several organizational re-designs aimed at optimizing team output and enhancing collaboration. She develops and maintains streamlined processes for approvals, enabling simultaneous product launches in multiple forms. Eblin also manages Assistant Toxicologists and interacts with Non-governmental organizations to align company policy on testing requirements and validation of new alternative methods for toxicology testing.